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Background: Extrapulmonary tuberculosis (EPTB) is associated with high rates of morbidity and mortality. Diagnosis of
EPTB is challenging in resource-limited settings due to difficulties in obtaining samples, as well as the paucibacillarity of
the specimens. Skeletal tuberculosis accounts for 10–35 % of EPTB cases, with vertebral osteomyelitis (Pott’s disease)
representing 50 % of the cases. We present two cases of suspected Pott’s disease, diagnosed through GeneXpert MTB/
RIF assay in urine at a rural Tanzanian hospital.
Case Presentation: Case I
A 49-year old male, HIV-1 positive, on co-formulated tenofovir disoproxil fumarate/lamivudine/efavirenz since
2009 and CD4 counts of 205 cells/μL (13 %). He presented with lower back pain and progressive lower limb
weakness for two weeks prior to admission. The physical examination revealed bilateral flaccid paraplegia with
reduced reflexes, but otherwise unremarkable findings. A lateral lumbar X-ray showed noticeable reduction of
intervertebral space between L4 and L5, and a small calcification in the anterior longitudinal ligament between
L4 and L5, being compatible with focal spondylosis deformans but inconclusive with regard to tuberculous
spondylitis. An abdominal ultrasound showed normal kidneys, bladder and prostate gland. The urinalysis and
complete blood counts (CBC) were normal. M. Tuberculosis was detected through GeneXpert MTB/RIF in centrifuged
urine, with no resistance to rifampicin.
Case II
A 76-year old female, HIV-1 negative, presented with lower back pain and progressive weakness and numbness of the
lower limbs for two months prior to admission. The physical examination revealed paraplegia, but otherwise
unremarkable findings. The lumbosacral X-ray findings were compatible with spondylosis deformans of the
lumbar spine and possible tuberculous spondylitis in L3-L4. The abdominal and renal ultrasound showed
normal kidneys and bladder. The urinalysis and CBC were normal. M. Tuberculosis was detected through GeneXpert
MTB/RIF in centrifuged urine, with no resistance to rifampicin.
Conclusion: We report two cases of suspected tuberculous spondylitis diagnosed through Xpert MTB/RIF in urine
samples from a rural Tanzanian hospital. Urine testing using Xpert MTB/RIF reflects disseminated disease and renal
involvement, and may offer a feasible additional diagnostic approach for Pott’s disease in rural Africa.
Keywords: Tuberculosis, Vertebral spondylitis, Xpert MTB/RIF, Pott’s disease, Urine, Case report* Correspondence: gsikalengo@ihi.or.tz
1Ifakara Health Institute, Ifakara, Tanzania
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Sikalengo et al. BMC Infectious Diseases  (2016) 16:514 Page 2 of 6Background
Extra-pulmonary Tuberculosis (EPTB) is common
among people living with HIV/AIDS (PLHIV) in sub-
Saharan Africa and is associated with significant morbid-
ity and mortality. Skeletal tuberculosis accounts for 10
to 35 % of all EPTB cases, vertebral osteomyelitis being
the most common form accounting for around 50 % of
all cases [1]. In resource-limited facilities, diagnosis is
difficult and relies on clinical and radiographic findings.
This approach has limited diagnostic accuracy and often
leads to late diagnosis, with signs of spinal cord com-
pression at admission in 40 to 70 % of cases [2]. Xpert
MTB/RIF (Cepheid, Sunnyvale, USA) assay is currently
recommended by the WHO for the diagnosis of some
forms of EPTB, but this does neither include spinal tu-
berculosis nor urine testing. Despite previous studies
have shown that M. tuberculosis DNA can be detected
in urine samples from patients with pulmonary TB and
EPTB [3], to our knowledge, the diagnosis of Pott’s dis-
ease through Xpert MTB/RIF in urine has never been
reported to date.
Case presentation
Case I
A 49-year-old man living with HIV since 2009 was ad-
mitted to our hospital with a complaint of lower back
pain for one year. He presented with lower limb weak-
ness for two weeks prior to admission, initially present-
ing with reduced proximal power in the right lower limb
(grade 3/5) and progressive involvement of both lower
limbs and development of bilateral flaccid paraplegia. He
was on antiretroviral therapy (ART) with co-formulated
tenofovir disoproxil fumarate (TDF)/lamivudine (3TC)
/efavirenz (EFV), and good adherence. He did not have
cough, weight loss or night sweats.
On admission, he was afebrile, and his blood pressure,
heart rate, respiratory rate, and oxygen saturation were
within normal ranges. The neurological examination re-
vealed no meningeal signs, no cranial nerve palsies, nor-
mal strength, sensitivity and reflexes in upper limbs,
flaccid paraparesia and reduced reflexes in lower limbs,
preserved bowel and bladder habits and no ataxia. He
did not have any palpable deformity on his back, and
otherwise he had an unremarkable physical examination.
Investigations
A lateral lumbar X-ray showed harmonic lordosis, regu-
lar spinal alignment, normal height of vertebral bodies,
noticeable reduction of intervertebral space between L4
and L5, small calcification in the anterior longitudinal
ligament between L4 and L5, no obvious destruction of
vertebra L4 and L5, being inconclusive with regard to
tuberculous spondylitis (Fig. 1a). However, the assess-
ment was limited due to overlaying intestinal gases. Thechest radiograph was normal. An abdominal ultrasound
showed normal kidneys, bladder and prostate gland. Due
to the suspicion of extra-pulmonary TB with spinal in-
volvement, we performed the Xpert MTB/RIF assay in
centrifuged urine, which detected M. Tuberculosis, with
no resistance to rifampicin (Table 1). His CD4 count was
205 cells/μL (13 %), and the complete blood counts
(CBC), AST, ALT, creatinine and urinalysis were within
normal ranges.
Treatment
Due to the acute nature and progression of the lower
limb weakness, the patient was given IV dexamethasone
16 mg in 24 h (4 mg 6hrly in 24 h), with progressive
tapering down in 1 week and continuation with oral
prednisolone 1.5 mg/kg, tapered down in a period of
4 weeks. Standard antitubercular treatment was started
with co-formulated rifampicin 150 mg, isoniazid 75 mg,
pyrazinamide 400 mg and ethambutol hydrochloride
275 mg daily for 2 months, to be followed by rifampicin
150 mg and isoniazid 75 mg daily for 4 months adjusted
to weight. He continued with his ART regimen, initiating
physiotherapy later in the course of treatment.
Outcomes
The patient was discharged from hospital upon request
from relatives. Despite reporting an initial progressive
improvement in power in both lower limbs, he died at
home 3 months after starting TB treatment due to non-
documented reasons. We could not rule out lack of
adherence to anti-tubercular drugs.
Case II
A 76 year old woman, HIV negative, presented with a
2 month history of lower back pain and a 2 week history
of progressive weakness and numbness of the lower
limbs without a prior history of trauma. She complained
of night sweats and occasional fever without respiratory
symptoms. Neurological examination revealed no men-
ingeal signs, no cranial nerve palsies, normal strength,
sensitivity and reflexes in upper limbs, flaccid paraplegia
and areflexia, preserved bowel and bladder habits and
no ataxia. She did not have any palpable deformity on
her back, and otherwise, the rest of the physical examin-
ation was unremarkable.
Investigations
Determine HIV-1/2 (Alere, Waltham, USA) was nega-
tive. A lateral lumbosacral X-ray showed reduced height
of vertebra L3 with moderate angulation of the vertebral
body; lateral and ventral osteophytes; reduced interverte-
bral spaces, maximum at L3/L4; and sclerosis of inter-
vertebral joints, maximum at L4/L5 and L5/S1. These
findings were compatible with spondylosis deformans of
Fig. 1 Lumbar Radiographies of Both Patients. a Patient 1: Lumbar lateral X-ray showing harmonic lordosis, regular spinal alignment, normal
height of vertebral bodies, noticeable reduction of intervertebral space between L4 and L5, small calcification in the anterior longitudinal ligament
between L4 and L5, with no obvious destruction of vertebra L4 and L5. b Patient 2: Lumbosacral X-ray showing straightening of thoraco-lumbar
region, regular spinal alignment, reduced height of vertebra L3 with moderate angulation of the vertebral body, lateral and ventral osteophytes,
reduced intervertebral spaces, maximum at L3/L4 and sclerosis of intervertebral joints maximum at L4/L5 and L5/S1
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dylitis in L3–L4 (Fig. 1b). A chest radiograph was not
performed. An abdominal and renal ultrasound showed
normal kidneys and bladder. The stool analysis, urinaly-
sis and CBC were normal. Due to the suspicion of extra-
pulmonary TB with spinal involvement, we performed
the Xpert MTB/RIF assay on centrifuged urine, which
detected M. tuberculosis, with no resistance to rifampi-
cin (Table 1).
Treatment
Standard antitubercular treatment was started with co-
formulated rifampicin 150 mg, isoniazid 75 mg, pyrazina-
mide 400 mg and ethambutol hydrochloride 275 mg daily
for 2 months, to be followed by rifampicin 150 mg and
isoniazid 75 mg daily for 4 months, adjusted to weight.
The possibility of transfer for surgical treatment was
offered but not possible due to economic constraints.Table 1 Showing cycle thresholds (ct) values of each probe for pati
Sample type MTB Result RIF Result Probe D P
Patient 1 Urine Positive Susceptible 31.1
Patient 2 Urine Positive Susceptible 34.2Outcomes
At the time of hospital discharge, she had neither back
pain nor more fever or night sweats. She had reduced
reflexes without significant changes in power. She
attended one physiotherapy visit and never returned to
the hospital. She was taken by her relatives to another
region, stopped treatment and died at home due to non-
documented reasons.
Differential diagnoses
Tuberculous spondylitis most commonly affects the
angles of vertebral bodies and thoracic and lumbar inter-
vertebral joints leading to vertebral narrowing and even-
tually vertebral collapse. There are a wide number of
diseases that can present with low back pain and lower
limb weakness, including intervertebral discopathies,
malignancies, infections, and inflammatory, vascular, and
metabolic causes.ent 1 and patient 2
robe C Probe E Probe B Probe A SPC QC-1 QC-2
29.3 31.8 30.0 30.3 26.4 0.0 0.0
33.3 35.7 33.3 23.3 34.0 0.0 0.0
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stenosis as a possible initial diagnosis. Despite the lack
of proper imaging techniques, the physical examination
was not compatible. Malignancies like multiple mye-
loma, spinal cord tumours and other metastases, are in
the spectrum of the differential diagnosis,and could not
be reliably ruled out with the available imaging tech-
niques and lack of histopathology diagnostic facilities.
Transverse myelitis and its etiologies is among the dif-
ferential diagnosis. Infections associated with transverse
myelitis include HIV, HTLV-1, herpes viruses,Lyme dis-
ease,mycoplasma, brucella, syphilis, Zika virus, and
schistosomiasis. Some of these infections could not be
ruled out due to diagnostic limitations, and others (such
as syphilis or schistosomiasis) were not assessed after
having a positive Xpert MTB/RIF result. Other non-
infectious causes of transverse myelitis include multiple
sclerosis, acute disseminated encephalomyelitis, neuro-
sarcoidosis, paraneoplastic syndromes, and systemic in-
flammatory autoimmune disorders such as ankylosing
spondilitis, antiphospholipid antibody syndrome, Behçet
disease, mixed connective tissue disease, rheumathois
arthritis, scleroderma, Sjögren syndrome and systemic
lupus erythematosus. None of these diseases was consid-
ered due to the lack of associated compatible symptoms.
Other infectious causes like bacterial osteomyelitis and
epidural abscesses could have caused a similar clinical
picture. However, the plain radiographs, although not
sensitive enough for diagnosing osteomyelitis, were not
compatible. Other diseases such as acute inflammatory
demyelinating polyneurolopathy (Guillain-Barré syn-
drome), vascular myelopathies like anterior spinal artery
infarction due to atherosclerosis or embolic disease and
metabolic causes like vitamin B12 deficiency should also
be considered. Again, these entities could not be reliably
ruled out due to diagnostic limitations. However, the
chronic clinical evolution is non-compatible with arterial
spinal artery infarction; the lack of ascending weakness
typically seen in Guillain-Barré syndrome was not ob-
served; and the absence of macrocytic anaemia, although
not excluding it, makes the diagnosis of vitamin B12
deficiency unlikely.
To reach a definitive diagnosis, well-equipped micro-
biology and histopathology laboratories would have been
needed, as well as imaging studies like MRI and CT
scans. Unfortunately, none of these are available neither
at our facility nor at the average rural hospital in
Tanzania. In addition, CSF analysis can be important to
exclude some of the above pathologies,
Given these diagnostic limitations, a rational workup
to diagnose Pott’s disease in the context of compatible
symptoms adapted to rural Africa would include: a
complete blood count; an erythrocyte sedimentation rate
(which can be markedly elevated in Pott’s Disease); achest radiograph; a dorso-lumbar radiograph (despite
radiographic changes associated with Pott’s disease present
relatively late and are difficult to interpret by clinicians
without training in radiology); and, based on our experi-
ence with these two cases, an Xpert MTB/RIF in urine. In
the two cases reported, the high specificity and positive
predictive value of Gene xpert MTB/RIF assay in the frame
of a high prevalence of tuberculosis in our area, we are
confident that both patients had tuberculosis.
Discussion
Tanzania is among the 22 high TB burden countries,
which collectively account for more than 80 % of the
global burden for tuberculosis. The prevalence of tuber-
culosis in Tanzania is 295/100,000 people and more
prevalent in males than females. Worldwide, EPTB
accounts for 25 % of all TB cases, and even higher per-
centages in HIV-infected individuals, which can repre-
sent 15–50 % of the total TB incidence in HIV prevalent
settings. In some studies bone and joint TB accounts for
around 15–20 % of all EPTB cases in high prevalence
settings but the true incidence is still unknown [4].
Existing tests are limited in accuracy and time to diagno-
sis, and require invasive procedures, which are often not
available in rural settings of low-income countries.
The Xpert MTB/RIF assay has been widely implemented
in sub-Saharan Africa. However, few data are still available
after this implementation. One study conducted in a pri-
mary care clinic in rural South Africa has shown that this
test could increase the number of patients starting TB
treatment and reduce delay in treatment initiation [5].
Neverthelessit does not seem to have an effect in reduction
of TB related morbidity [6]. The Xpert MTB/RIF assay is
able to detect both the presence of Mycobacterium tuber-
culosis complex DNA and rifampicin drug-resistance in
2 h. The test has excellent accuracy when performed in
sputum and was endorsed for the initial diagnosis of TB
and multi drug resistant-TB by the WHO in 2010 for this
purpose [7]. Information regarding its performance in
non-sputum specimens is emerging, but it is not suffi-
ciently validated in HIV-prevalent settings. Recent recom-
mendations from WHO [8] propose Xpert MTB/RIF as a
replacement test for specific non-respiratory specimens
but not urine, blood or stool samples due to lack of suffi-
cient evidence.
Two studies including a large number of non-respiratory
samples including biopsy specimens from tissues, lymph
nodes and fine-needle aspirates, pus, urine, gastric aspi-
rates, body fluids including synovial, pericardial, pleural,
peritoneal, and cerebrospinal fluid specimens tested with
Xpert MTB/RIF demonstrated a high diagnostic accuracy
for EPTB. Sensitivity varied widely across different sample
types [9, 10]. A meta-analysis evaluating Xpert MTB/RIF
performance for EPTB showed a sensitivity of 83.1 %
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59.0–92.2 %) for TB meningitis and 46.4 % (95 % CI 26.3–
67.8 %) for pleural fluid [11].
A number of previous studies showed that M. tubercu-
losis DNA can be detected in urine samples. Sensitivity,
specificity and techniques used varied between studies.
In a study evaluating non-sputum samples for diagnosis
of EPTB, six culture confirmed urine samples were in-
cluded, and M. Tuberculosis was detected in all samples
by Xpert MTB/RIF [3]. To date, in the largest study in-
cluding urine samples for diagnosis of EPTB, Xpert
MTB/RIF was positive in 11 of 13 positive urine cul-
tures, corresponding to a sensitivity of 87.5 % (95 % CI:
71–104) [10]. In people with unknown HIV status, Xpert
MTB/RIF has been shown to have relatively good sensitiv-
ity. While the sensitivity reported in HIV infected outpa-
tients prior to ART initiation was 19 % [12], a role for urine
testing using Xpert MTB/RIF has been suggested among
hospitalized HIV-infected patients, showing a higher diag-
nostic yield than sputum (64 % vs 27 %) [13–15]. Detection
of M. tuberculosis in urine reflects disseminated disease
but in our case both patients had no leukocituria and had
normal abdominal ultrasound scans.
The most common symptom of Pott’s disease is pro-
gressively increasing local pain over weeks to months.
Constitutional symptoms are present in less than 40 % of
cases. Progression of untreated disease may lead to spinal
compression and paraplegia [4]. Early diagnosis of Pott’s
disease is pivotal to start immediate treatment for TB and
improve prognosis. Late presentation may lead to ad-
vanced neurological deficits requiring long rehabilitation
and carrying a worse prognosis [16]. Performance of Xpert
MTB/RIF in tuberculosis spondylitis has been reported in
very few studies. In culture and histology confirmed 71
samples from 69 individuals suspected of Pott’s disease,
Xpert MTB/RIF had a sensitivity of 95.6 % and specificity
of 96.2 % [17]. Diagnosis of tuberculous spondylitis using
Xpert MTB/RIF in rural Tanzania has been previously re-
ported in a HIV-negative patient presenting with a para-
spinal abscess, and detected in tissue sample through fine
needle aspiration [18]. One of the limitations of our report
is that the cause of death in both of these cases could not
be ascertained, and a definitive diagnosis of Pott’s disease
could not be reached. However, both cases were shown to
have tuberculosis and were diagnosed with advanced
neurological impairment with suggestive radiological find-
ings in one of them. Reactivation of infection with pro-
gression to clinical disease can happen in the context of
immunosuppression due to several factors. Both patients
had some degree of immunosuppression, one due to HIV
infection with low CD4 counts and the other one due to
old age. We believe that late presentation with advanced
disease as well as withdrawal from follow-up led to the
poor outcome of both patients.Surgical treatment is recommended in subjects with
Pott’s disease and neurological symptoms. However,
good outcomes using a conservative approach with anti-
tuberculous treatment only, have also been reported [19].
In the two cases presented, referral to specialized hospitals
for surgical treatment was not possible due to economic
constrains of the patients.
Conclusions
The etiologic diagnosis of Pott’s disease remains prob-
lematic in rural sub-Saharan Africa, and Xpert MTB/
RIF may provide an affordable adjunct diagnostic
approach in both HIV and non-HIV patients. We
present two cases of Pott’s disease diagnosed through
Xpert MTB/RIF in urine samples. To our knowledge,
this has never been reported before, and larger stud-
ies are needed to assess the feasibility and impact of
this approach.
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